Decision Aid for Education and Support About Cancer Treatment
NCT06191679 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 117
Last updated 2025-01-06
Summary
The goals of this clinical trial are to evaluate DECIDES, a web-based decision support application that provides education about cancer and cancer treatment and provides support to encourage adolescent and young adult (AYA) patients, their caregivers, and oncology health care providers to make informed decisions about cancer treatment together.
The main questions this study aims to answer are:
* Is DECIDES acceptable, usable, and feasible for AYA, caregivers, and oncology health care providers?
* Is DECIDES helpful for AYA, caregivers, and oncology health care providers that are making cancer treatment decisions together?
AYA and caregiver participants will complete a questionnaire and be randomly assigned to participate in one of three groups: (1) Usual Care, (2) DECIDES, or (3) DECIDES+. Participants in 'Usual Care' will continue to have access to their oncology health care team for questions related to cancer and cancer treatment, as per usual standard of care. Participants in both 'DECIDES' and 'DECIDES+' groups will receive access to DECIDES, and those in 'DECIDES+' will receive additional live, coach-assisted support. After 8 weeks, AYA and caregivers will complete a follow-up questionnaire and those in the 'DECIDES' and 'DECIDES+' groups will complete a semi-structured qualitative interview. Oncology clinicians of participating AYA will be invited to participate in a semi-structured qualitative interview. Researchers will compare groups to see if AYA and caregivers that receive access to DECIDES (with an informational handout vs. coach-assisted support) report more positive decision-making processes compared to those that receive standard of care.
Conditions
- Cancer
- Childhood Cancer
Interventions
- BEHAVIORAL
-
Decision Aid for Education and Support about Cancer Treatment (DECIDES Intervention)
DECIDES is a developmentally appropriate, engaging, and interactive web-based decision support intervention for AYA diagnosed with cancer (and their caregivers) that includes components written for low health literacy. Components include: * Education on cancer and cancer treatments, including clinical trials * An exercise to identify perceived barriers and benefits to treatment options * An exercise to clarify personal goals for treatment that align with life goals * Resources to support communication with the oncology health care team
Sponsors & Collaborators
-
Children's Hospital of Philadelphia
lead OTHER
Principal Investigators
-
Lamia Barakat, PhD · Children's Hospital of Philadelphia
Study Design
- Allocation
- RANDOMIZED
- Purpose
- SUPPORTIVE_CARE
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 15 Years
- Max Age
- 24 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2020-07-08
- Primary Completion
- 2023-04-13
- Completion
- 2023-04-13
Countries
- United States
Study Locations
More Related Trials
-
Treatment of Acute Lymphoblastic Leukemia in Children
NCT00165178 ·Status: COMPLETED ·Phase: PHASE3
-
Bright Ideas - CIN Feasibility Study
NCT04929899 ·Status: RECRUITING ·Phase: NA
-
Identifying, Understanding, and Overcoming Barriers to the Use of Clinical Practice Guidelines in Pediatric Oncology
NCT02847130 ·Status: COMPLETED
-
Development of Strategies to Increase Enrollment in Clinical Trials for Children With Cancer
NCT00002485 ·Status: COMPLETED
-
Evaluation and Natural History of Children With Cancer and AIDS
NCT00001424 ·Status: COMPLETED
-
Combination Chemotherapy in Treating Young Patients With Recurrent or Resistant Malignant Germ Cell Tumors
NCT00467051 ·Status: COMPLETED ·Phase: PHASE2
-
Pemetrexed Disodium in Treating Young Patients With Recurrent Solid Tumors
NCT00070473 ·Status: COMPLETED ·Phase: PHASE1
-
Testing the Addition of an Anti-cancer Drug, DT2216, to the Usual Chemotherapy Treatment for Relapsed or Refractory Solid Tumors and Fibrolamellar Carcinoma
NCT06620302 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Combination Chemotherapy in Treating Children With Non-Hodgkin's Lymphoma
NCT00003650 ·Status: COMPLETED ·Phase: PHASE3
-
Combination Chemotherapy With or Without Peripheral Stem Cell Transplant in Treating Children With Acute Lymphoblastic Leukemia
NCT00022737 ·Status: COMPLETED ·Phase: PHASE3
-
Individualized High Dose Methotrexate to Treat Cancer in Children Who Have a Significant Risk for Side Effects to Methotrexate
NCT02076997 ·Status: COMPLETED ·Phase: NA
-
Evaluation, Treatment, and Natural History of Children and Young Adults With Cancer or Rare Diseases
NCT00001686 ·Status: COMPLETED
-
Medical Treatment Decision Making Using Adaptive Conjoint Analysis
NCT02608307 ·Status: TERMINATED
-
Combination Chemotherapy in Treating Children With Stage III or Stage IV Non-Hodgkin's Lymphoma or Acute Lymphoblastic Leukemia
NCT00003217 ·Status: COMPLETED ·Phase: PHASE1
-
High-Intensity Parent Intervention Program in Improving Learning and School Functioning in Latino Children With Acute Leukemia or Lymphoblastic Lymphoma
NCT03178617 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Neurobehavioral Complications in Children Who Were Previously Treated With Steroids and Intrathecal Therapy for Acute Lymphoblastic Leukemia
NCT00085176 ·Status: COMPLETED
-
Decitabine, Doxorubicin, and Cyclophosphamide in Treating Children With Relapsed or Refractory Solid Tumors or Neuroblastoma
NCT00075634 ·Status: COMPLETED ·Phase: PHASE1
-
Combination Chemotherapy in Treating Children With Newly Diagnosed Acute Lymphocytic Leukemia
NCT00003671 ·Status: COMPLETED ·Phase: PHASE2
-
Combination Chemotherapy in Treating Young Patients With Advanced Solid Tumors
NCT00281944 ·Status: COMPLETED ·Phase: PHASE1
-
Long-Term Effects of Treatment in Patients Previously Treated for Childhood Hodgkin's Lymphoma
NCT00091091 ·Status: COMPLETED
-
Oxaliplatin in Treating Young Patients With Recurrent Solid Tumors That Have Not Responded to Previous Treatment
NCT00091182 ·Status: COMPLETED ·Phase: PHASE2
-
Home Chemotherapy Intervention for Children With Cancer - a Feasibility Study
NCT05372536 ·Status: COMPLETED ·Phase: NA
-
Combination Chemotherapy in Treating Children With Non-testicular Malignant Germ Cell Tumors
NCT00002489 ·Status: COMPLETED ·Phase: PHASE2
-
Mobile Health Case Management System for Reducing Pediatric Treatment Abandonment
NCT03677128 ·Status: COMPLETED ·Phase: NA
-
Combination Chemotherapy in Treating Children With Lymphoma
NCT00002590 ·Status: COMPLETED ·Phase: PHASE2